CTRI/2023/10/058543尚未招募2 期
Randomized Controlled Trial for Efficacy of Transcranial Direct Current Stimulation (tDCS) in Patients with Episodic Migraine. - NI
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •diagnosed of having episodic migraine with more than 4 and less than 15 migrainous headache days per month and less than 15 headache days per month with persistent headaches despite of one month of stable migraine preventive treatment presenting to the OPD/ emergency in Neurology department of CMC Ludhiana.
排除标准
- •1. Other neurological or neuropsychiatric diseases
- •2. Other chronic painful syndromes
- •3. Other types of primary or secondary headaches
- •4. Epilepsy
- •5. Metallic head implants or cardiac pacemaker
- •6. Pregnancy or lactation
- •7. Substance abuse
- •8. Brain surgery
- •9. Prior experience with tDCS
- •10. Known brain metastasis
- •11. Use of botulinum toxin in head and neck region during the 6 months prior to screening.
研究者
相似试验
未知
3 期
Randomized control trial on efficacy of transcatheter arterial chemoembolization with cisplatin-lipiodol suspension or epirubicin-lipiodol emulsion for hepatocellular carcinoma.Hepatocellular carcinomaJPRN-UMIN000001153Department of Gastroenterology and Hepatology, Okayama University Graguate School of Medicine, Dentistry and Pharmaceutical Sciences.360
进行中(未招募)
4 期
Trial of tDCS as Early Augmentation in Adults with DepressioCTRI/2022/01/039123King Georges Medical University Lucknow
尚未招募
不适用
An Effectiveness Randomized Controlled Trial of Treating Moderate Tic Disorder in Children by Combining Chinese and Western MedicineTic disorder in childrenITMCTR2200006502Guang'anmen Hospital, Chinese Academy of Traditional Chinese Medicine
招募中
3 期
Safety and efficacy of tDCS as an early augmentation (add on to medications) strategy in management of Obsessive Compulsive DisorderCTRI/2023/02/049682King Georges Medical University
已完成
3 期
Trial of tDCS in adolescents with OCD as early augmentatioCTRI/2021/12/039002King Georges Medical University21
